A new hybrid anthracycline antibiotic was produced by heterologous expression of dnrK encoding carminomycin 4-0-metyltransferase in an epelmycin-producing Streptomyces violaceus. pMKlOO was constructed by insertion of Steptomyces peucetius dnrK gene in
violaceus. pMKlOO was constructed by insertion of Steptomyces peucetius dnrK gene in
Steptomyces-Qx^xQsion vector pIJ6021
and introduced to the epelmycin producer. The transformant produced a hybrid anthracycline antibiotic together with host epelmycins when cultured in antibiotic production medium in the presence of thiostrepton. The hybrid anthracycline was determined to be 7-0-L-rhodosaminyl-4-0-methyl-£-rhodomycinone (4-0-methylepelmycin D). However, the attempts on production of hybrid 4-0-methylaclarubicin and 4-0-methyl-l-deoxyobelmycin by the transformants of aclarubicin and 1-deoxyobelmycin producers with pMKlOOwere unsuccessful. medium18)was used in transformation experiments. E. coli strain with or without plasmid was grown in Luria-Bertani medium and selected with ampicillin (50 /xg/ml). Medium for antibiotic production was described previously19).
Protoplast Preparation and Transformation
Streptomyces sp. protoplasts were prepared by a modification of the standard procedure18). The strains were shake-cultured in a 500-ml Sakaguchi flask containing 100ml of SS medium and 8g of glass beads (3mm in diameter) for 3 days. The mycelial cells collected from one flask by centrifugation were washed twice with 30ml of sterile 10%sucrose and resuspended in 20ml of P buffer supplemented with egg lysozyme (3 mg/ml). After 1-hour incubation at 30°C, the resultant solution was filtered through a glass tube (20 mmin diameter) packed with glass 829 wool (15 mmin length) and the protoplasts were collected from the filtrate by centrifugation at 3000rpm for 10 minutes. The protoplasts washed with 20ml of P buffer were suspended into 1 ml of P buffer to give a cell density of more than about 108/ml. Transformation was carried out according to the standard procedure18) and transformants were selected by overlaying 2ml of kanamycin layer (2 mg/ml).
Construction of Expression Plasmid for dnrK Gene
The dnrK encoding CM4-(9-methyltransferase13) was isolated by PCRmethod. Total DNAof S. peucetius ATCC 2905 was used as a temperate for PCR. The primers DK1 
Antibiotic Production
The transformants with f>MK100were cultured in a 500-ml Sakaguchi flask containing 50ml of seed medium:
soybean meal 10g, glucose 5 g, soluble starch 5 g, KH2PO4 1 g, NaCl 2g and MgSO4-H2O0.5g per liter tap water, pH 7.2. After cultivation for 3 days at 30°C, 1 ml of seed was inoculated into twenty 500-ml Sakaguchi flasks containing 75 ml each of antibiotic production medium20). Kanamycin was added finally at 5/ig/ml to seed medium and production medium. Cultivation was carried out at 30°C for 7 days on a reciprocal shaker (130rpm). Thiostrepton was added at final 5/ig/ml to the culture on day 2 in order to express the dnrK gene and cultivation was continued for further 5 days to give a maximumantibiotic yield. As control experiment, the transformants with pIJ6021 were also cultivated in the samemanner.
TLC and HPLC Assays Usually, 5 ml of culture broth was taken and mixed with 5 ml of acetone by Vortex. The mixture was extracted twice with 2ml of CHC13. The CHC13 layer was pooled and concentrated to dryness, and the residual pigment was tested for whole antibiotics by TLC. The above extract was also subjected to acid hydrolysis by heating in 1 ml of0.1 N HC1 at 85°C for 30 minutes to release aglycone and sugar. Biological Activity Inhibitory effects of the products on growth and nucleic acids syntheses in murine L1210 leukemia cell culture were examined as previously described20). IC50 is expressed as a drug concentration required to inhibit by 50%control of the growth and nucleic acids syntheses of the cultured L1210 cells.
General
UVspectra were determined on a Shimadzu UV-160A spectrophotometer and IR spectrometer on a Jasco FT/IR-5300. ]H and 13C NMRwere recorded with a Jeol GSX-400 spectrometer at 500MHz and 125MHz, respectively.
Chemical shifts were expressed in 8 value (ppm) with TMS as an internal reference and coupling constants are given in J (Hz). Mass spectra were recorded with Jeol SX102 Digital Polarimeter.
Results

Antibiotic Production by Three Transformants with pMKlOO
Vector pMKlOO containing dnrK gene was prepared from a transformant S. lividans (pMKlOO)and introduced and 6U-21 (pMKlOO) were selected by overlaying 2 ml of2 mg/ml ofkanamycin soft agar. pIJ6021 was also introduced to these three host strains to give transformants SU2-730 (pIJ6021), SC-7 (pIJ6021) and 6U-21 (pIJ6021) in the same manner. Antibiotic production by three pairs of the transformants were tested.
ACRs, EMPs and 1-deoxyOBMs are structurally aklavinone (AKN) glycosides, £-RMN glycosides and /3-RMN diglycerides, respectively, and their major components are shown in Fig. 2 . Host strain 6U-21 produced two major ACRcomponents A and B. Strain SU2-730 produced five EPMcomponents and strain SC-7 did 1-deoxyOBMsof more than 7 components. All these componentsdiffered in the sugar chain of a trisaccharide moiety from one another. In order to see easy the effect of introducing dnrK gene to these anthracycline producers, we examined by TLC 4-<9-methyl derivatives of AKN, e-RMN and /3-RMN which would occur from their possible products by mild acid hydrolysis.
These 4-Omethyl aglycones are distinguishable from the corresponding non 4-O-methyl aglycones by TLC. The results are shown in Fig. 3 where the occurrence of a new spot different from that of parental aglycone was observed with SU2-730 (pMKlOO) but not with two other transformants SC-7 (pMKlOO) and 6U-21 (pMKlOO). HPLC also confirmed the presence of the new aglycone which was corresponding to 4-0-methyl-£-RMN in the retention time (Fig. 4) . We thus concluded that heterologous expression of dnrK gene led to the production of hybrid anthracycline antibiotic in EPM producer but not in ACR and 1-deoxyOBM producers. Whenwhole antibiotics were extracted from both the cultures of SU2-730 (pMKlOO) and and analyzed by TLC, it was found that the former coproduced a new spot of antibiotic with five spots of parental EPMs A~E (Fig. 5) . centrifuged. The antibiotic products were extracted with 500 ml of acetone from mycelial cake. The acetone extract was evaporated to about 200ml and extracted twice with 200ml of CHC13 after adjustment of pH to 8.5. The under layers were pooled and evaporated to a small volume. An excess of /2-hexane was added to precipitate the crude products (415mg). This crude powder was chromatographed on a silica gel column (30mm in diameter, Wakogel C-200, 100g), which was eluted with solvent systems of CHC13-MeOH(100: 1-100: 30). The eluate was fractionated every 10 ml and monitored by TLC.
The new compound was eluted when the column was developed with CHCl3-MeOH (100: 10). The fractions were pooled and evaporated to dryness, followed by further purification on preparative TLC. Single and major pigmented band was scrapped off and eluted with CHC13-MeOH (5 : 1). The extract was evaporated to dryness and dissolved in 5ml of 1% acetic acid. The solution was
washed with 5 ml of toluene by Vortex. The aqueous layer was taken, adjusted to pH 7.5 with 4n NaOHand extracted with 5 ml of CHC13. After washed with distilled water, the CHC13 layer was dried over anhydrous Na2SO4 and concentrated to a small volume and an excess of /2-hexane was added to precipitate pure orange compound. The yield was 4.6mg.
Structural Determination
Since it was anticipated that the new compound was 4-Omethyl derivative of either one of EPMs, we determined the aglycone and sugar of the newcompoundby TLCafter acid 
the HMBC spectrum, indicating that the new compound was an A^V-dimethyl derivative of compound D788-5.
Thus, the structure of the new compoundwas determined to
Biological Activity
The biological activities of 4-0-methyl EPM-D, EPM-D and their AyV-didemethyl analogs (D788-5 and D788-6)17) against leukemic LI210 cell culture were tested for the inhibition of growth and nucleic acids syntheses under the continuous exposure and are shown in Table 3 . 4-O-Methyl EPM-Dwas somewhat less active in the growth inhibition, but more active in the inhibition of RNA and DNA syntheses, than EPM-D. It was much more active concerning both the activities than its JV,AT-didemethyl analogs, compound D788-5 which was produced by a blocked mutant of DNRproducer17). As results, it was found that 4-O-methyl EPM-Dwas comparable to DNRin the biological activities in vitro against L12 10 cell culture. (pMKlOO) and SC-7 (pMKlOO) could not produce hybrid 4-0-methyl derivatives since all of their products are the trisaccharide type which are unavailable substrate for dnrK enzyme. We have investigated the microbial 4-0-methylation of some important anthracyclines using a specific DNR-nonproducing mutant strain DKN-1 and obtained respective 4-0-methyl derivatives from D788-6, oxaunomycin, betaclamycin T and yellamycin A8), all of which are the monosaccharide-type of anthracyclines. These findings show that there is the possibility of an extensive use of pMKlOO to direct production of 4-0-methyl anthracycline when strain improvements are achieved to accumulate mainly such a monosaccharide-type of anthracyclines.
